SCHEMBL8272011

SCHEMBL8272011

CCCCN1CC(c2ccc(OC)c3oc4ccccc4c23)CC1=O

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.62
MAOA P21397 4/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
CYP17A1 P05093 1/20 0.39
CYP19A1 P11511 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 2/20 0.38
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8271479 0.90 PDE10A (0.66) PDE10AMAOANPC1RAB9AKDM4E
SCHEMBL8271489 0.89 PDE10A (0.63) PDE10AMAOANPC1RAB9AKDM4E
SCHEMBL2558017 0.88 PDE10A (0.58) PDE10AMAOANPC1RAB9AKDM4E
SCHEMBL7705223 0.86 PDE10A (0.59) PDE10AMAOANPC1RAB9AKDM4E
SCHEMBL2556919 0.86 PDE10A (0.51) PDE10ANPC1RAB9AALDH1A1LMNA
SCHEMBL8271478 0.85 PDE10A (0.63) PDE10AMAOANPC1RAB9AKDM4E
SCHEMBL8272031 0.85 PDE10A (0.59) PDE10AMAOANPC1RAB9AKDM4E
SCHEMBL8271339 0.85 PDE10A (0.59) PDE10AMAOANPC1RAB9AKDM4E
SCHEMBL8271493 0.85 PDE10A (0.65) PDE10AMAOANPC1RAB9AKDM4E
SCHEMBL2556902 0.84 PDE10A (0.54) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006011024-A9 NEW TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LTD (IN) 2006-06-08 WO disclosed
WO-2006011024-A2 NEW TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LTD. (US) 2006-02-02 WO disclosed